Literature DB >> 3017398

Enhanced transplantability of human ovarian cancer lines in cyclophosphamide-pretreated nude mice.

M M Nauta, E Boven, H M Schlüper, C A Erkelens, H M Pinedo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3017398      PMCID： PMC2001520          DOI： 10.1038/bjc.1986.181

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  23 in total

1.  Divergent effects of cyclophosphamide administration on mononuclear killer cells: quantitative depletion of cell numbers versus qualitative suppression of functional capabilities.

Authors:  G W Hunninghake; A S Fauci
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

2.  Clinical pharmacology of cyclophosphamide.

Authors:  C M Bagley; F W Bostick; V T DeVita
Journal:  Cancer Res       Date:  1973-02       Impact factor: 12.701

3.  The regulation of macrophage activity in congenitally athymic mice.

Authors:  A K Sharp; M J Colston
Journal:  Eur J Immunol       Date:  1984-01       Impact factor: 5.532

4.  Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity.

Authors:  R B Herberman; M E Nunn; D H Lavrin
Journal:  Int J Cancer       Date:  1975-08-15       Impact factor: 7.396

5.  Macrophages of athymic nude mice: Fc receptors, C receptors, phagocytic and pinocytic activities.

Authors:  V Vĕtvicka; L Fornůsek; M Holub; J Zídková; J Kopecek
Journal:  Eur J Cell Biol       Date:  1984-09       Impact factor: 4.492

6.  Effect of cyclophosphamide on survival of mice and incidence of metastatic tumor following intravenous and intracardial inoculation of tumor cells.

Authors:  T L Vollmer; F K Conley
Journal:  Cancer Res       Date:  1984-09       Impact factor: 12.701

7.  Comparative activity and distribution studies of five platinum analogues in nude mice bearing human ovarian carcinoma xenografts.

Authors:  E Boven; W J van der Vijgh; M M Nauta; H M Schlüper; H M Pinedo
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701

8.  Growth of tumor cells with different sensitivities for murine natural killer cells in young and adult athymic nude mice.

Authors:  J C Romijn
Journal:  Exp Cell Biol       Date:  1985

9.  Secondary screening of platinum compounds in human ovarian cancer xenografts in nude mice.

Authors:  E Boven; M M Nauta; H M Schluper; F Elferink; W J van der Vijgh; H M Pinedo
Journal:  Eur J Cancer Clin Oncol       Date:  1985-10

10.  Ovarian tumour xenografts in the study of the biology of human epithelial ovarian cancer.

Authors:  M L Friedlander; P Russell; I W Taylor; M H Tattersall
Journal:  Br J Cancer       Date:  1985-03       Impact factor: 7.640
View more
  2 in total

Review 1.  Human tumor xenografts as model for drug testing.

Authors:  J Mattern; M Bak; E W Hahn; M Volm
Journal:  Cancer Metastasis Rev       Date:  1988-11       Impact factor: 9.264

2.  Targeted Cancer Therapy with a Novel Anti-CD37 Beta-Particle Emitting Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma.

Authors:  Ada H V Repetto-Llamazares; Roy H Larsen; Sebastian Patzke; Karianne G Fleten; David Didierlaurent; Alexandre Pichard; Jean Pierre Pouget; Jostein Dahle
Journal:  PLoS One       Date:  2015-06-11       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.